Literature DB >> 18991110

Wilcoxon-Mann-Whitney test: stratify or not?

Yongming Qu1, Yan D Zhao, Dewi Rahardja.   

Abstract

The Wilcoxon-Mann-Whitney (WMW) test is the most commonly used nonparametric method to compare two treatments when the underlying distribution of the outcome variable is not normally distributed. In the presence of stratum effects, the van Elteren (vE) test, a stratified WMW test, can be used to adjust for the stratum effect. We provide guidance on how to choose between the two tests in the design phase of clinical trials and in the analysis of clinical data. We show by simulations that both tests preserve the type I error rate regardless of the presence of the stratum effects. Therefore, the test with greater power is preferred. In comparing powers, we found that the WMW test is better when the stratum effects are small, whereas the vE test is better when the stratum effects are large. Finally, when the stratum effects are moderate, the decision depends on the shape of the distribution and the ratio of the number of strata and the number of subjects. In this case, results presented in this article or from similar simulations may be used to determine which test is better.

Mesh:

Year:  2008        PMID: 18991110     DOI: 10.1080/10543400802369103

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  3 in total

1.  Detailed statistical analysis plan for the pulmonary protection trial.

Authors:  Katrine B Buggeskov; Janus C Jakobsen; Niels H Secher; Thomas Jonassen; Lars W Andersen; Daniel A Steinbrüchel; Jørn Wetterslev
Journal:  Trials       Date:  2014-12-23       Impact factor: 2.279

2.  PANSAID - PAracetamol and NSAID in combination: study protocol for a randomised trial.

Authors:  Kasper Højgaard Thybo; Daniel Hägi-Pedersen; Jørn Wetterslev; Jørgen Berg Dahl; Henrik Morville Schrøder; Hans Henrik Bülow; Jan Gottfrid Bjørck; Ole Mathiesen
Journal:  Trials       Date:  2017-01-10       Impact factor: 2.279

3.  PANSAID-PAracetamol and NSAID in combination: detailed statistical analysis plan for a randomised, blinded, parallel, four-group multicentre clinical trial.

Authors:  Kasper Højgaard Thybo; Janus Christian Jakobsen; Daniel Hägi-Pedersen; Niels Anker Pedersen; Jørgen Berg Dahl; Henrik Morville Schrøder; Hans Henrik Bülow; Jan Gottfrid Bjørck; Søren Overgaard; Ole Mathiesen; Jørn Wetterslev
Journal:  Trials       Date:  2017-10-10       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.